PhD Monitor
/Detail
Biomedical Sciences● OpenPostdoc⏰ 13 days leftPreview

Research Fellow in CAR-T Analytics

Develop novel in vivo CAR-T cell therapies for autoimmune diseases using cutting-edge lentiviral vector technologies.

Best for:Best for molecular biologists and gene therapy researchers with hands-on expertise in lentiviral vector engineering and CAR potency assays.

UCL · London, United Kingdom · R2 · Recognised researcher
More professors at UCL
CAR-T cell therapyLentiviral vectorsGene therapyImmunotherapyPreclinical models
This is a postdoc position — not a PhD studentship.
Deadline
Until filled
rolling
Funding
Salaried
£47.2k/yr
Start date
flexible
Fixed-term
Location
London
United Kingdom

Overview

UCL is seeking a dedicated Research Fellow to join the Division of Surgery and Interventional Science on a Versus Arthritis Translational Award. Working alongside Professor John Counsell, the successful candidate will drive in vivo preclinical research focused on developing targeted CAR-T cell therapies for lupus and inflammatory arthritis. Responsibilities include administering T cell-targeted vectors intravenously to humanised mouse models to evaluate generation efficiency, persistence, and target cell elimination. Applicants are expected to hold a relevant PhD and bring robust hands-on expertise in molecular biology, vector engineering, and immunological assays.

CAR-T AnalyticsVector EngineeringMolecular BiologyTranslational ResearchImmunologyPreclinical In Vivo

What you'll do

  • Lead the in vivo preclinical work package administering T cell-targeted vectors intravenously to humanised mouse models.
  • Develop and evaluate in vivo CAR-T cell therapies for lupus and inflammatory arthritis using proprietary UCL lentiviral technologies.
  • Compare targeting envelopes and vector backbones for CAR-T generation efficiency, persistence, and biodistribution.
  • Assess CD19+ target cell elimination and perform comprehensive CAR potency assays.
  • Collaborate across cross-disciplinary teams involving clinicians, engineers, and researchers.

Requirements

Degree required: PhD in molecular biology, bioengineering, gene therapy or a closely related discipline (awarded, or submitted/near completion)

Language: English

Instruction: English

Required skills
  • Hands-on experience of lentiviral vector engineering, production, purification, and titration
  • Experience of vector retargeting, including engineering of envelope glycoproteins and pseudotyping
  • Experience of CAR potency assays such as antigen-specific cytotoxicity, killing assays, and cytokine release
Nice to have
Publications in gene therapy, vector engineering, or immunotherapyConference presentations in gene therapy, vector engineering, or immunotherapy

Funding & terms

Type
Salaried
Amount
£47.2k/yr
Duration
—
Programme
Versus Arthritis Translational Award
Versus Arthritis

How to apply

Deadline: 2026-11-04 (Europe/London) · open until filled

Submit your application through the official UCL job portal before the closing date. Early application is strongly recommended as the advertisement may close early upon receiving a high volume of applications.

Documents required
  • CV
↗Apply on site

Contact

John Counsell· Professor

JC
Prof.
John Counsell
Division of Surgery and Interventional Science
Lab
Division of Surgery and Interventional Science
UCL
Versus Arthritis Translational AwardUnited Kingdom
See the full position

Create a free profile to unlock your personal match score, the full requirements, funding details and how to apply — in English or Persian.

No card · 10 free AI match scores
Ready to apply?
13 days until the deadline — open this position on its website.